Abbott Laboratories said on Friday it expects to begin releasing EleCare formula in the coming weeks from its recently reopened Sturgis plant, which has been at the center of a baby formula shortage in the United States.
The company had shut down the plant in February and recalled its infant formula, including Similac and EleCare, after reports of bacterial infections in babies who had consumed products made at the facility.
